a public good project by the
Synthesis
Company
of California

© 2026

Cédric Rébé | doi.page

0 works0 citations0 h-index

Cédric Rébé

Inserm(FR)Centre Georges François Leclerc(FR)

Publications by Year

Research Areas

Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Immune Cell Function and Interaction, Inflammasome and immune disorders, Cancer Research and Treatments

Most-Cited Works

→ 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity(2010)1,212 cited
→ Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells(2010)981 cited
→ Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth(2012)766 cited
→ The receptor NLRP3 is a transcriptional regulator of TH2 differentiation(2015)396 cited
→ Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression(2012)324 cited
→ Interleukin-1β and Cancer(2020)305 cited

→ Specific involvement of caspases in the differentiation of monocytes into macrophages(2002)

301 cited

→ Resveratrol-induced Apoptosis Is Associated with Fas Redistribution in the Rafts and the Formation of a Death-inducing Signaling Complex in Colon Cancer Cells(2003)287 cited

→ Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen(2016)256 cited

→ In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival(2011)223 cited